Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease

Recruiting

Phase 1

Phase 2

CRISPR_SCD001Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease

Sponsor:

Mark Walters, MD

Code:

NCT04774536

Conditions

Sickle Cell Disease

Eligibility Criteria

Sex: All

Age: 12 - 35

Healthy Volunteers: Not accepted

Interventions

CRISPR_SCD001

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Mark Walters, MD on 2024-09-20.